Annual Shareholders Equity
$892.80 K
+$1.87 M+191.33%
31 December 2023
Summary:
INVO Bioscience annual stockholders equity is currently $892.80 thousand, with the most recent change of +$1.87 million (+191.33%) on 31 December 2023. During the last 3 years, it has fallen by -$6.42 million (-87.79%). INVO annual shareholders equity is now -87.79% below its all-time high of $7.31 million, reached on 31 December 2021.INVO Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
-$23.32 K
-$1.39 M-101.71%
30 September 2024
Summary:
INVO Bioscience quarterly stockholders equity is currently -$23.32 thousand, with the most recent change of -$1.39 million (-101.71%) on 30 September 2024. Over the past year, it has dropped by -$916.12 thousand (-102.61%). INVO quarterly shareholders equity is now -100.32% below its all-time high of $7.31 million, reached on 31 December 2021.INVO Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INVO Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -102.6% |
| 3 y3 years | -87.8% | -100.3% |
| 5 y5 years | +124.0% | +99.4% |
INVO Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -87.8% | +191.3% | -100.3% | +98.6% |
| 5 y | 5 years | -87.8% | +124.0% | -100.3% | +99.5% |
| alltime | all time | -87.8% | +117.9% | -100.3% | +99.5% |
INVO Bioscience Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$23.32 K(-101.7%) |
| June 2024 | - | $1.36 M(>+9900.0%) |
| Mar 2024 | - | $10.20 K(-98.9%) |
| Dec 2023 | $892.80 K(-191.3%) | $892.80 K(+139.5%) |
| Sept 2023 | - | $372.80 K(-121.9%) |
| June 2023 | - | -$1.71 M(-2027.1%) |
| Mar 2023 | - | $88.50 K(-109.1%) |
| Dec 2022 | -$977.60 K(-113.4%) | -$977.60 K(-175.9%) |
| Sept 2022 | - | $1.29 M(-61.6%) |
| June 2022 | - | $3.36 M(-40.0%) |
| Mar 2022 | - | $5.59 M(-23.5%) |
| Dec 2021 | $7.31 M(+27.3%) | $7.31 M(+181.8%) |
| Sept 2021 | - | $2.59 M(-40.5%) |
| June 2021 | - | $4.36 M(-22.2%) |
| Mar 2021 | - | $5.60 M(-2.5%) |
| Dec 2020 | $5.74 M(-254.7%) | $5.74 M(-247.2%) |
| Sept 2020 | - | -$3.90 M(+8.4%) |
| June 2020 | - | -$3.60 M(-18.9%) |
| Mar 2020 | - | -$4.43 M(+19.4%) |
| Dec 2019 | -$3.71 M(+36.3%) | -$3.71 M(-1.2%) |
| Sept 2019 | - | -$3.76 M(+19.0%) |
| June 2019 | - | -$3.16 M(+1.8%) |
| Mar 2019 | - | -$3.10 M(+13.9%) |
| Dec 2018 | -$2.72 M(-45.4%) | -$2.72 M(-38.5%) |
| Sept 2018 | - | -$4.43 M(+7.1%) |
| June 2018 | - | -$4.13 M(-15.8%) |
| Mar 2018 | - | -$4.91 M(-1.7%) |
| Dec 2017 | -$4.99 M | -$4.99 M(+2.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2017 | - | -$4.88 M(+1.6%) |
| June 2017 | - | -$4.80 M(+1.9%) |
| Mar 2017 | - | -$4.72 M(+2.1%) |
| Dec 2016 | -$4.62 M(+22.9%) | -$4.62 M(+6.4%) |
| Sept 2016 | - | -$4.34 M(+5.1%) |
| June 2016 | - | -$4.13 M(+4.9%) |
| Mar 2016 | - | -$3.94 M(+4.8%) |
| Dec 2015 | -$3.76 M(-13.8%) | -$3.76 M(+28.4%) |
| Dec 2014 | -$4.36 M(+14.3%) | - |
| Dec 2013 | -$3.81 M(+13.1%) | - |
| Dec 2012 | -$3.37 M(+15.3%) | - |
| Dec 2011 | -$2.93 M(+17.9%) | -$2.93 M(-0.2%) |
| Sept 2011 | - | -$2.93 M(+0.9%) |
| June 2011 | - | -$2.90 M(+9.1%) |
| Mar 2011 | - | -$2.66 M(+7.3%) |
| Dec 2010 | -$2.48 M(-23.3%) | -$2.48 M(+2.3%) |
| Sept 2010 | - | -$2.43 M(-0.2%) |
| June 2010 | - | -$2.43 M(+12.8%) |
| Mar 2010 | - | -$2.16 M(-33.4%) |
| Dec 2009 | -$3.24 M(+378.4%) | -$3.24 M(-29.3%) |
| Sept 2009 | - | -$4.58 M(+211.7%) |
| June 2009 | - | -$1.47 M(+34.7%) |
| Mar 2009 | - | -$1.09 M(+61.1%) |
| Dec 2008 | -$676.60 K(-2533.8%) | -$676.60 K(+5064.9%) |
| Sept 2008 | - | -$13.10 K(-4466.7%) |
| June 2008 | - | $300.00(-97.0%) |
| Mar 2008 | - | $9900.00(-64.4%) |
| Dec 2007 | $27.80 K(-25.9%) | $27.80 K |
| Dec 2006 | $37.50 K | - |
FAQ
- What is INVO Bioscience annual stockholders equity?
- What is the all time high annual shareholders equity for INVO Bioscience?
- What is INVO Bioscience quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for INVO Bioscience?
- What is INVO Bioscience quarterly shareholders equity year-on-year change?
What is INVO Bioscience annual stockholders equity?
The current annual shareholders equity of INVO is $892.80 K
What is the all time high annual shareholders equity for INVO Bioscience?
INVO Bioscience all-time high annual stockholders equity is $7.31 M
What is INVO Bioscience quarterly stockholders equity?
The current quarterly shareholders equity of INVO is -$23.32 K
What is the all time high quarterly shareholders equity for INVO Bioscience?
INVO Bioscience all-time high quarterly stockholders equity is $7.31 M
What is INVO Bioscience quarterly shareholders equity year-on-year change?
Over the past year, INVO quarterly stockholders equity has changed by -$916.12 K (-102.61%)